Cheng et al. reported that BTLA antibody treatment increased the levels of cytokines and chemokines and promoted the recruitment of inflammatory cells into the peritoneal cavity, leading to deteriorated organ damage and increased mortality in mice with hemorrhagic shock/sepsis (76). This evidence concerns the gene BTLA and Sepsis.